Unknown

Dataset Information

0

The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells.


ABSTRACT:

Background

Large-scale genomic analyses of patient cohorts have revealed extensive heterogeneity between individual tumors, contributing to treatment failure and drug resistance. In malignant melanoma, heterogeneity is thought to arise as a consequence of the differentiation of melanoma-initiating cells that are defined by cell-surface markers like CD271 or CD133.

Results

Here we confirmed that the nerve growth factor receptor (CD271) is a crucial determinant of tumorigenicity, stem-like properties, heterogeneity and plasticity in melanoma cells. Stable shRNA mediated knock-down of CD271 in patient-derived melanoma cells abrogated their tumor-initiating and colony-forming capacity. A genome-wide expression profiling and gene-set enrichment analysis revealed novel connections of CD271 with melanoma-associated genes like CD133 and points to a neural crest stem cell (NCSC) signature lost upon CD271 knock-down. In a meta-analysis we have determined a shared set of 271 differentially regulated genes, linking CD271 to SOX10, a marker that specifies the neural crest. To dissect the connection of CD271 and CD133 we have analyzed 10 patient-derived melanoma-cell strains for cell-surface expression of both markers compared to established cell lines MeWo and A375. We found CD271+ cells in the majority of cell strains analyzed as well as in a set of 16 different patient-derived melanoma metastases. Strikingly, only 2/12 cell strains harbored a CD133+ sub-set that in addition comprised a fraction of cells of a CD271+/CD133+ phenotype. Those cells were found in the label-retaining fraction and in vitro deduced from CD271+ but not CD271 knock-down cells.

Conclusions

Our present study provides a deeper insight into the regulation of melanoma cell properties and points CD271 out as a regulator of several melanoma-associated genes. Further, our data strongly suggest that CD271 is a crucial determinant of stem-like properties of melanoma cells like colony-formation and tumorigenicity.

SUBMITTER: Redmer T 

PROVIDER: S-EPMC4010406 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells.

Redmer Torben T   Welte Yvonne Y   Behrens Diana D   Fichtner Iduna I   Przybilla Dorothea D   Wruck Wasco W   Yaspo Marie-Laure ML   Lehrach Hans H   Schäfer Reinhold R   Regenbrecht Christian R A CR  

PloS one 20140505 5


<h4>Background</h4>Large-scale genomic analyses of patient cohorts have revealed extensive heterogeneity between individual tumors, contributing to treatment failure and drug resistance. In malignant melanoma, heterogeneity is thought to arise as a consequence of the differentiation of melanoma-initiating cells that are defined by cell-surface markers like CD271 or CD133.<h4>Results</h4>Here we confirmed that the nerve growth factor receptor (CD271) is a crucial determinant of tumorigenicity, st  ...[more]

Similar Datasets

| S-EPMC2898751 | biostudies-literature
| S-EPMC5574914 | biostudies-literature
| S-EPMC6006357 | biostudies-literature
| S-EPMC7564075 | biostudies-literature
| S-ECPF-GEOD-51259 | biostudies-other
| S-EPMC5719420 | biostudies-literature
| S-EPMC4170612 | biostudies-literature
| S-EPMC9977483 | biostudies-literature
| S-EPMC1134053 | biostudies-literature
| S-EPMC3093514 | biostudies-literature